Shukra Pharmaceuticals receives LoA from RMSCL
European Commission approves Eylea 8 mg with extended 6-month treatment interval for nAMD and visual impairment due to DME
FDA approves removal of REMS programs within Bristol Myers Squibb’s cell therapy labels
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes